Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.

Tinmouth J, Lansdorp-Vogelaar I, Allison JE.

Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3. Review.

PMID:
26041750
2.

A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.

Vasilyev S, Smirnova E, Popov D, Semenov A, Eklund C, Hendolin P, Paloheimo L, Syrjänen K.

Anticancer Res. 2015 May;35(5):2873-80.

PMID:
25964570
3.

Epidemiology and screening: what's new?

Bonelli L.

Colorectal Dis. 2015 Jan;17 Suppl 1:10-4. doi: 10.1111/codi.12815. No abstract available.

PMID:
25511855
4.

Advances in Fecal Occult Blood Tests: the FIT revolution.

Young GP, Symonds EL, Allison JE, Cole SR, Fraser CG, Halloran SP, Kuipers EJ, Seaman HE.

Dig Dis Sci. 2015 Mar;60(3):609-22. doi: 10.1007/s10620-014-3445-3. Epub 2014 Dec 10. Review.

5.

Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.

Sakata N, Sakata Y, Shimoda R, Sakata H, Iwakiri R, Fujimoto K, Mizuguchi M, Irie H, Shimoda Y, Noshiro H.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1224-8.

PMID:
25436287
6.

[Colorectal cancer screening: a work in progress].

Bretagne JF.

Presse Med. 2014 Nov;43(11):1165-7. doi: 10.1016/j.lpm.2014.08.004. Epub 2014 Sep 26. French. No abstract available.

PMID:
25261917
7.

Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program.

Chiang TH, Chuang SL, Chen SL, Chiu HM, Yen AM, Chiu SY, Fann JC, Chou CK, Lee YC, Wu MS, Chen HH.

Gastroenterology. 2014 Dec;147(6):1317-26. doi: 10.1053/j.gastro.2014.08.043. Epub 2014 Sep 6.

8.

Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.

Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, Lantieri O, Launoy G, Guittet L.

Int J Cancer. 2015 Apr 15;136(8):1827-34. doi: 10.1002/ijc.29187. Epub 2014 Sep 18.

PMID:
25195670
9.

Controversies in colorectal cancer screening.

Pox CP.

Digestion. 2014;89(4):274-81. doi: 10.1159/000363287. Epub 2014 Jul 11. Review.

10.

The psychological impact of participating in colorectal cancer screening by faecal immuno-chemical testing--the Australian experience.

Bobridge A, Bampton P, Cole S, Lewis H, Young G.

Br J Cancer. 2014 Aug 26;111(5):970-5. doi: 10.1038/bjc.2014.371. Epub 2014 Jul 1.

11.

Attendance and yield over three rounds of population-based fecal immunochemical test screening.

Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME.

Am J Gastroenterol. 2014 Aug;109(8):1257-64. doi: 10.1038/ajg.2014.168. Epub 2014 Jul 1.

PMID:
24980879
12.

Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.

Hillyer GC, Schmitt KM, Freedberg DE, Kramer RA, Su Y, Rosenberg RM, Neugut AI.

Am J Prev Med. 2014 Aug;47(2):182-7. doi: 10.1016/j.amepre.2014.03.011. Epub 2014 Jun 17.

13.

Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers review.

Sawbridge D, Probert C.

J Gastrointestin Liver Dis. 2014 Jun;23(2):195-202. Review.

14.

Colorectal cancer: from prevention to personalized medicine.

Binefa G, Rodríguez-Moranta F, Teule A, Medina-Hayas M.

World J Gastroenterol. 2014 Jun 14;20(22):6786-808. doi: 10.3748/wjg.v20.i22.6786. Review.

15.

Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.

Auge JM, Pellise M, Escudero JM, Hernandez C, Andreu M, Grau J, Buron A, López-Cerón M, Bessa X, Serradesanferm A, Piracés M, Macià F, Guayta R, Filella X, Molina R, Jimenez W, Castells A; PROCOLON Group.

Gastroenterology. 2014 Sep;147(3):628-636.e1. doi: 10.1053/j.gastro.2014.06.008. Epub 2014 Jun 14.

PMID:
24937264
16.

KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.

Battaglia P, Baritono E, Remo A, Vendraminelli R, Conti A.

Tumori. 2014 Mar-Apr;100(2):122-7. doi: 10.1700/1491.16391.

PMID:
24852854
17.

Patient perceptions of stool DNA testing for pan-digestive cancer screening: a survey questionnaire.

Yang D, Hillman SL, Harris AM, Sinicrope PS, Devens ME, Ahlquist DA.

World J Gastroenterol. 2014 May 7;20(17):4972-9. doi: 10.3748/wjg.v20.i17.4972.

18.

Tests and investigations for colorectal cancer screening.

Carroll MR, Seaman HE, Halloran SP.

Clin Biochem. 2014 Jul;47(10-11):921-39. doi: 10.1016/j.clinbiochem.2014.04.019. Epub 2014 Apr 24. Review.

PMID:
24769265
19.

Current and future molecular diagnostics in colorectal cancer and colorectal adenoma.

Tsang AH, Cheng KH, Wong AS, Ng SS, Ma BB, Chan CM, Tsui NB, Chan LW, Yung BY, Wong SC.

World J Gastroenterol. 2014 Apr 14;20(14):3847-57. doi: 10.3748/wjg.v20.i14.3847. Review.

20.

Colorectal cancer screening: 20 years of development and recent progress.

Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, Seifert B, Dusek L.

World J Gastroenterol. 2014 Apr 14;20(14):3825-34. doi: 10.3748/wjg.v20.i14.3825. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk